Skip to content

OS Therapies OSTX Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)

Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five) at other companies

Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$1.79M+134%
Landmark Bancorp logo
Landmark BancorpLARK
$57K-70.0%
FIP
FTAI Infrastructure Inc.FIP
$22.84M-12.9%
Kadant logo
KadantKAI
$174.06M+28.8%
Financial Institutions logo
Financial InstitutionsFISI
$484K-29.2%
Home Bancorp logo
Home BancorpHBCP
$96K-66.7%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's finite-lived intangible assets - expected amortization expense (year five).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's finite-lived intangible assets - expected amortization expense (year five)?
OS Therapies (OSTX) reported finite-lived intangible assets - expected amortization expense (year five) of $4.02M in Q1 2026.
What does finite-lived intangible assets - expected amortization expense (year five) mean?
This represents the projected non-cash expense associated with the consumption of finite-lived intangible assets in the fifth year following the reporting period. It helps investors model long-term profitability and the impact of asset aging on future earnings.